Albipagrastim alfa

阿格司亭α

Report date: 2025/06/09 14:19:22

Base Information

Drug NameAlbipagrastim alfa
Drug Alias NameRecombinant (yeast secreted) human serum albumin-human granulocyte colony stimulating factor (I) fusion protein重组(酵母分泌型)人血清白蛋白-人粒细胞集落刺激因子(Ⅰ)融合蛋白迈粒生MAILISHENGGW-003 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonistsHaematopoiesis stimulants
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile NeutropeniaNeutropeniaLeukopenia
Global Approved IndicationsChemotherapy-Induced Febrile Neutropenia
Approved Indications in ChinaChemotherapy-Induced Febrile Neutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2025/05/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu T-Mab Bio-Pharmaceuticals Co LtdJiangsu Haibo Biopharmaceutical Co LtdQilu Pharmaceutical Co Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsChemotherapy-Induced Febrile NeutropeniaNeutropeniaLeukopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A